Ionis Pharmaceuticals, Inc. (IONS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 51.86 |
| Open | 52.34 |
| Bid | 51.40 x 400 |
| Ask | 51.47 x 200 |
| Day's Range | 51.05 - 52.34 |
| 52 Week Range | 35.95 - 54.44 |
| Volume | |
| Avg. Volume | 1,350,842 |
| Market Cap | 7.51B |
| Beta (5Y Monthly) | 0.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.67 |
| Earnings Date | Aug 01, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 60.45 |
ZacksIonis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Should You Buy?
Ionis Pharmaceuticals (IONS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksIonis (IONS) Up 6% on Detailed Data From Angelman Drug Study
Data from an early-stage study shows that treatment with Ionis' (IONS) ION582 helps improve communication, cognition and motor function in patients with Angelman syndrome, a rare nerve disorder.
Investor's Business DailyIonis Pharmaceuticals Surges Into Buy Zone As It, Possibly, Proves Biogen Wrong
Ionis Pharmaceuticals stock surged Monday after the company unveiled promising results for a drug that treats a rare genetic condition.
© 2024 Yahoo. All rights reserved.